ArticleIn vitro cellular & developmental biology. Animal2021
Induction of cardiomyocyte calcification is dependent on FoxO1/NFATc3/Runx2 signaling.
Article in In vitro cellular & developmental biology. Animal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Phosphoglycerate Dehydrogenase Overexpression Inhibits Ferroptosis to Repress Calcification of Human Coronary Artery Vascular Smooth Muscle Cells via the P53/SLC7A11 Pathway.International journal of general medicine · 2024Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
Cardiovascular disorders (CAVDs) being a major concern over the past several years due to the huge number of morbidity and mortality worldwide, a number of studies have been done on the various aspects of cardiac problems. One of the various CAVDs is cardiovascular calcification. A number of investigations and research work have been done previously on the molecular mechanism of vascular and heart valve calcification but the mechanism of myocardial and cardiomyocyte calcification has remained uninvestigated. A number of case studies have shown the presence of calcific deposits in the myocardial/ventricular region of the heart in fetal condition as well as in individuals of different ages but no detailed studies have been done yet. In this study, we have mainly investigated the role of Forkhead box transcription factor FoxO1 and nuclear factor of activated T-cells NFATc3 in cardiomyocyte calcification. Our studies in H9c2 cardiomyocytes show that calcific deposition in cardiomyocytes does not occur in 15 d but upon osteogenic induction for 1 mo where FoxO1 expression gets reduced thereby increasing the expression of its downstream target NFATc3, thus increasing the expression of the osteogenic marker Runx2. Detailed studies on the molecular mechanism of cardiomyocyte calcification will help in finding out therapeutic strategies in the treatment of cardiac calcification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.